Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's ...

A few decades ago, the idea of an HIV cure sounded unrealistic. Today, doctors describe a carefully documented case where the ...

Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...

Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...

The Noguchi Memorial Institute for Medical Research (NMIMR) has developed what scientists describe as “ground-breaking ...

Gilead Sciences and Assembly Biosciences have announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) ...

The Noguchi Memorial Institute for Medical Research (NMIMR) has developed what scientists are calling a potential breakthrough in HIV treatment, following successful laboratory tests on two herbal ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...

Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Earlier this month, on World AIDS Day, Dec. 1, 2025, scientists published a paper in the journal “Nature” detailing the seventh case of a ...